UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer

European journal of cancer (1990), 2016-01, Vol.52, p.1-9

2016

Volltextzugriff (PDF)

Are New ypN Stages Predictive of Survival in 477 Lung Cancer Patients Who Underwent Trimodality Therapy for Initial pN2 Disease?

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S198-S198

2016

Volltextzugriff (PDF)

PO-0696: Prognostic impact of celiac/supraclavicular node metastasis in locally advanced oesophageal cancer

Radiotherapy and oncology, 2016-04, Vol.119, p.S325-S326

2016

Volltextzugriff (PDF)

MA03.03 Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage IA Non-small Cell Lung Cancer: A Prospective Cohort Study

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S49-S50

2022

Volltextzugriff (PDF)

P2.05-13 Impact of Diffusing Capacity for Postoperative Pulmonary Complications in Patients Without Obstructive Pulmonary Disease

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S752-S752

2019

Volltextzugriff (PDF)

P1.18-24 Neoadjuvant Therapy versus Upfront Surgery for NSCLC Patients with Clinically Suspected Subaortic or Paraaortic Lymph Nodes

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S636-S636

2019

Volltextzugriff (PDF)

P15.01 Phase II Prospective Study of Adjuvant Pembrolizumab in N2 Positive NSCLC Treated With Neoadjuvant CCRT Followed by Surgery

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1014-S1014

2021

Volltextzugriff (PDF)

OA10.02 Recommended Change for N Descriptor Proposed by the IASLC: A Validation Study from a Single-Center Experience

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S231-S231

2019

Volltextzugriff (PDF)

Randomized phase ii trial comparing chemoradiotherapy with chemotherapy for completely resected unsuspected N2-positive non-small cell lung cancer

Annals of oncology, 2017-09, Vol.28, p.v457-v457

2017

Volltextzugriff (PDF)

P3.01-81 Long-Term Outcome of Surgically Resected Unsuspected N2 Lung Adenocarcinoma

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S898-S898

2018

Volltextzugriff (PDF)

P1.16-14 Impact of Smoking on Treatment Outcome in Early Squamous Cell Lung Cancer (T1N0)

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S632-S632

2018

Volltextzugriff (PDF)

MA08.03 Adjuvant Pembrolizumab in N2 Positive NSCLC Treated with Concurrent Chemoradiotherapy Followed by Surgery: Phase II, Prospective Study

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S278-S278

2019

Volltextzugriff (PDF)

A randomized phase II study of leucovorin, 5-fluorouracil with or without oxaliplatin (LV5FU2 vs. FOLFOX) for curatively-resected, node-positive esophageal squamous cell carcinoma

Annals of oncology, 2016-10, Vol.27, p.vi218-vi218

2016

Volltextzugriff (PDF)

P3.02-011 A Prospective Study of Serial Circulating Tumor DNA Assessment in Detecting Recurrence of Resected Early-stage Lung Cancer

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2241-S2241

2017

Volltextzugriff (PDF)

P1.08-004 Adjuvant Chemoradiotherapy vs. Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2015-S2015

2017

Volltextzugriff (PDF)

P3.05-012 Clinicopathological Determinants of Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2294-S2294

2017

Volltextzugriff (PDF)

P3.16-41 Postoperative Pembrolizumab for the Patients with Pathologic Stage I Adenocarcinoma with Solid or Micropapillary Pattern

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S1017-S1017

2018

Volltextzugriff (PDF)

P3.01-082 Surgical Rebiopsy in Advanced Non-Small Cell Lung Cancer Resistant to Previous Chemotherapy

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2234-S2234

2017

Volltextzugriff (PDF)

P3.04-011 A Prospective Study to Optimize the Extent of Pulmonary Resection According to Decision-Making Algorithm in cStage IA NSCLC

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2289-S2289

2017

Volltextzugriff (PDF)

P2.01-57 Prognostic Implication of Clinical, Imaging, and Pathologic Parameters in N2(+) Stage IIIA Lung Cancer Patients

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S686-S687

2018

Volltextzugriff (PDF)

P3.08-006 Treatment Response and Survival Outcomes Are Associated with Histologic Type in Non-Small Cell Lung Cancer Treated with Trimodal Treatment

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2305-S2305

2017

Volltextzugriff (PDF)

Prognostic significance of venous invasion and maximum standardized uptake value of 18F-FDG PET/CT in surgically resected T1N0 esophageal squamous cell carcinoma

European journal of surgical oncology, 2017-02, Vol.43 (2), p.471-477

2017

Volltextzugriff (PDF)

Needs regarding care and factors associated with unmet needs in disease-free survivors of surgically treated lung cancer

Annals of oncology, 2013-06, Vol.24 (6), p.1552-1559

2013

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer

Are New ypN Stages Predictive of Survival in 477 Lung Cancer Patients Who Underwent Trimodality Therapy for Initial pN2 Disease?

PO-0696: Prognostic impact of celiac/supraclavicular node metastasis in locally advanced oesophageal cancer

MA03.03 Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage IA Non-small Cell Lung Cancer: A Prospective Cohort Study

P2.05-13 Impact of Diffusing Capacity for Postoperative Pulmonary Complications in Patients Without Obstructive Pulmonary Disease

P1.18-24 Neoadjuvant Therapy versus Upfront Surgery for NSCLC Patients with Clinically Suspected Subaortic or Paraaortic Lymph Nodes

P15.01 Phase II Prospective Study of Adjuvant Pembrolizumab in N2 Positive NSCLC Treated With Neoadjuvant CCRT Followed by Surgery

OA10.02 Recommended Change for N Descriptor Proposed by the IASLC: A Validation Study from a Single-Center Experience

Randomized phase ii trial comparing chemoradiotherapy with chemotherapy for completely resected unsuspected N2-positive non-small cell lung cancer

P3.01-81 Long-Term Outcome of Surgically Resected Unsuspected N2 Lung Adenocarcinoma

P1.16-14 Impact of Smoking on Treatment Outcome in Early Squamous Cell Lung Cancer (T1N0)

MA08.03 Adjuvant Pembrolizumab in N2 Positive NSCLC Treated with Concurrent Chemoradiotherapy Followed by Surgery: Phase II, Prospective Study

A randomized phase II study of leucovorin, 5-fluorouracil with or without oxaliplatin (LV5FU2 vs. FOLFOX) for curatively-resected, node-positive esophageal squamous cell carcinoma

P3.02-011 A Prospective Study of Serial Circulating Tumor DNA Assessment in Detecting Recurrence of Resected Early-stage Lung Cancer

P1.08-004 Adjuvant Chemoradiotherapy vs. Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer

P3.05-012 Clinicopathological Determinants of Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer

P3.16-41 Postoperative Pembrolizumab for the Patients with Pathologic Stage I Adenocarcinoma with Solid or Micropapillary Pattern

P3.01-082 Surgical Rebiopsy in Advanced Non-Small Cell Lung Cancer Resistant to Previous Chemotherapy

P3.04-011 A Prospective Study to Optimize the Extent of Pulmonary Resection According to Decision-Making Algorithm in cStage IA NSCLC

P2.01-57 Prognostic Implication of Clinical, Imaging, and Pathologic Parameters in N2(+) Stage IIIA Lung Cancer Patients

P3.08-006 Treatment Response and Survival Outcomes Are Associated with Histologic Type in Non-Small Cell Lung Cancer Treated with Trimodal Treatment

Prognostic significance of venous invasion and maximum standardized uptake value of 18F-FDG PET/CT in surgically resected T1N0 esophageal squamous cell carcinoma

Needs regarding care and factors associated with unmet needs in disease-free survivors of surgically treated lung cancer

Suchergebnisse filtern